Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MINOXIDIL, with a corresponding US DMF Number 6693.
Remarkably, this DMF maintains an Active status since its submission on November 25, 1986, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 21, 2022, and payment made on October 19, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II